JPRN-C000000140已完成3 期
Acarbose for Secondary Prevention of Cardiovascular Events in Patients With Coronary Stenting and Abnormal Glucose Tolerance - Acarbose and Secondary Prevention after Coronary Stenting
Institute of Biomedical Research and Innovation0 个研究点目标入组 300 人开始时间: 2005年9月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with abnormal glucose tolerance caused by other organic disorders such as pancreatitis, hemochromatosis, post pancreatectomy, hyperthyroidism, Cushing syndrome, Prader-Willi syndrome etc. 2)Patients with planned angioplasty. 3)Patients with uncontrollable congestive heart failure. 4)Less than 6 months since last episode of cerebral infarction. 5)Patients who have received medication for diabetes mellitus before. 6)AST(GOT) exceeding 100 IU/L or ALT(GPT) exceeding 100 IU/L. 7)Creatinine exceeding 2mg/dl. 8)Patients with a history of ileus or less than 6 months since celiotomy. 9)Pregnant women or those who plan pregnancy, or are in the lactation period. 10)Habitual drinker (more than 100ml/day of alcohol). 11)Patients with a history of gastrectomy. 12)Patients for whom it is impossible to follow up for 5 years. 13)Any other reason that the clinical supervisors or clinical researchers may have for considering a case unsuitable for the study.
研究者
相似试验
已完成
不适用
Secondary Prevention of Adverse Cardiovascular Events in Cases with Anomalous Origins of Coronary Arteries: Clinical Features, Management, and Long-Term OutcomeAnomalous Origin of the Coronary ArteryJPRN-UMIN000030629ihon University60
进行中（未招募）
1 期
Secondary Prevention of Cardiovascular Disease in the ElderlySecondary Prevention of Major Cardiovascular Events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in post MI cohort.MedDRA version: 20.0Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 100000004849EUCTR2015-002868-17-DEFundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)3,206
进行中（未招募）
1 期
Secondary Prevention of Cardiovascular Disease in the ElderlyEUCTR2015-002868-17-CZFundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)3,206
进行中（未招募）
不适用
Secondary Prevention of Cardiovascular Disease in the ElderlySecondary Prevention of Major Cardiovascular Events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in post MI cohort.MedDRA version: 18.1Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 100000004849EUCTR2015-002868-17-ESFundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)3,206
进行中（未招募）
1 期
Secondary Prevention of Cardiovascular Disease in the ElderlySecondary Prevention of Major Cardiovascular Events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in post MI cohort.MedDRA version: 20.0Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 100000004849EUCTR2015-002868-17-ITCENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III3,206